Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00256321
Recruitment Status : Terminated (Closed due to poor accrual)
First Posted : November 21, 2005
Last Update Posted : February 8, 2019
Information provided by (Responsible Party):
Chao Family Comprehensive Cancer Center, University of California, Irvine

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 2007
Actual Study Completion Date : August 2007